This cohort study assesses the treatment patterns (dosages and frequency) and the association of treatment with self-reported functional outcomes and quality of life among patients receiving onabotulinum toxin A for treatment of facial synkinesis.
http://bit.ly/2CWcW3q
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου